Jonathan has more than 32 years of worldwide regulatory, quality and clinical affairs experience across medical devices, combination products, diagnostics and human/veterinary pharmaceuticals.
Following completion of his PhD in veterinary pathophysiology, Jonathan began his career in regulatory affairs at A H Robins. He subsequently held regulatory affairs positions in drug and device companies, including Smith & Nephew, Glaxo, Bristol-Myers Squibb and ConvaTec. Jonathan has served on two European Commission Expert Working Groups on the Drug/Device Borderline and Device Classification. Jonathan now runs his own consulting firm, JHRA, specialising in medical device, IVD and combination product regulatory affairs.
Jonathan has been an active member of TOPRA since 1987; he is a Fellow and member of the Med Tech SPIN group and has been a regular contributor on numerous educational and training programmes, delivering Introductory Course lectures and acting as Module Advisor/lecturer for two of the TOPRA UH M.Sc. course modules.